Tag: Aravive Biologics

Aravive Biologics ovarian cancer drug AVB-S6-500 gets FDA fast track designation

pharmanewsdaily- August 20, 2018

Aravive Biologics has secured fast track designation from the US Food and Drug Administration (FDA) for its ovarian cancer drug AVB-S6-500 for the treatment of ... Read More